These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22730857)

  • 1. Impact of a phosphorylcholine-coated cardiac bypass circuit on blood loss and platelet function: a prospective, randomized study.
    Marguerite S; Levy F; Quessard A; Dupeyron JP; Gros C; Steib A
    J Extra Corpor Technol; 2012 Mar; 44(1):5-9. PubMed ID: 22730857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active or passive bio-coating: does it matters in extracorporeal circulation?
    Jacobs S; De Somer F; Vandenplas G; Van Belleghem Y; Taeymans Y; Van Nooten G
    Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylcholine-coated circuits improve preservation of platelet count and reduce expression of proinflammatory cytokines in CABG: a prospective randomized trial.
    Schulze CJ; Han L; Ghorpade N; Etches WS; Stang L; Koshal A; Wang SH
    J Card Surg; 2009; 24(4):363-8. PubMed ID: 19583605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass.
    De SF; Van BY; Caes F; François K; Arnout J; Bossuyt X; Taeymans Y; Van NG
    Perfusion; 2002 Jan; 17(1):39-44. PubMed ID: 11817528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface.
    De Somer F; François K; van Oeveren W; Poelaert J; De Wolf D; Ebels T; Van Nooten G
    Eur J Cardiothorac Surg; 2000 Nov; 18(5):602-6. PubMed ID: 11053824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostasis alterations in coronary artery bypass grafting: comparison between the off-pump technique and a closed coated cardiopulmonary bypass system.
    Scrascia G; Rotunno C; Guida P; Conte M; Amorese L; Margari V; Schinosa Lde L; Paparella D
    Interact Cardiovasc Thorac Surg; 2013 May; 16(5):636-42. PubMed ID: 23335652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery.
    Deptula J; Glogowski K; Merrigan K; Hanson K; Felix D; Hammel J; Duncan K
    J Extra Corpor Technol; 2006 Mar; 38(1):22-6. PubMed ID: 16637519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction.
    Heyer EJ; Lee KS; Manspeizer HE; Mongero L; Spanier TB; Caliste X; Esrig B; Smith C
    J Cardiothorac Vasc Anesth; 2002 Feb; 16(1):37-42. PubMed ID: 11854876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass.
    Ask A; Holt D; Smith L
    J Extra Corpor Technol; 2006 Mar; 38(1):27-32. PubMed ID: 16637520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
    Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
    Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular Alterations During Cardiac Surgery Using a Heparin or Phosphorylcholine-Coated Circuit.
    Dekker NAM; Veerhoek D; van Leeuwen ALI; Vonk ABA; van den Brom CE; Boer C
    J Cardiothorac Vasc Anesth; 2020 Apr; 34(4):912-919. PubMed ID: 31787433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial.
    Pappalardo F; Della Valle P; Crescenzi G; Corno C; Franco A; Torracca L; Alfieri O; Galli L; Zangrillo A; D'Angelo A
    Ann Thorac Surg; 2006 Mar; 81(3):886-91. PubMed ID: 16488689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
    Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early platelet recovery following cardiac surgery with cardiopulmonary bypass.
    Van Poucke S; Stevens K; Wetzels R; Kicken C; Verhezen P; Theunissen M; Kuiper G; van Oerle R; Henskens Y; Lancé M
    Platelets; 2016 Dec; 27(8):751-757. PubMed ID: 27164510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators.
    de Vroege R; van Oeveren W; van Klarenbosch J; Stooker W; Huybregts MAJM; Hack CE; van Barneveld L; Eijsman L; Wildevuur CRH
    Anesth Analg; 2004 Jun; 98(6):1586-1594. PubMed ID: 15155310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
    Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.